Presented at Molecular Med Tri-Con
MARCH 3, 2020
Navigating the path to developing Companion Diagnostics in Immuno-Oncology can be challenging. This presentation will discuss the approach to developing high quality prototype companion Dx IHC assays and their utility in patient selection and potential pivot to a Companion Dx approach.
Ask Your Questions
Have a question related to this presentation? Submit this form and we will get you answers.
